Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities    
Net income (loss) $ 19,653 $ 6,972
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,058 3,573
Equity-based compensation 5,553 4,920
Equity method investments (6,938) 412
Non-cash gain on securitization (11,061) (7,095)
Gain on sale of financing receivables and investments (1,655) (1,366)
Changes in financing receivables held-for-sale   5,382
Changes in accounts payable and accrued expenses 2,168 2,718
Other (129) (5,439)
Net cash provided by operating activities 13,649 10,077
Cash flows from investing activities    
Purchases of financing receivables (80,921) (106,874)
Principal collections from financing receivables 55,513 57,469
Proceeds from sales of financing receivables 51,389 29,032
Purchases of investments (10,991) (23,333)
Principal collections from investments 1,225 857
Proceeds from sales of investments   13,914
Purchases of real estate (118,963) (7,345)
Equity method investments (214,537) (10,706)
Equity method distributions received 33,772 27,903
Other (5,285) (1,550)
Net cash used in investing activities (288,798) (20,633)
Cash flows from financing activities    
Proceeds from credit facilities 277,612 117,400
Principal payments on credit facilities (168,801) (119,146)
Proceeds from nonrecourse debt 258,189  
Principal payments on nonrecourse debt (27,704) (41,429)
Payments on deferred funding obligations (73,927) (43,414)
Net proceeds of common stock issuances 98,399 91,516
Payments of dividends and distributions (33,020) (23,321)
Other (9,167) (5,912)
Net cash provided by (used in) financing activities 321,581 (24,306)
Increase (decrease) in cash, cash equivalents, and restricted cash 46,432 (34,862)
Cash, cash equivalents, and restricted cash at beginning of period 59,144 79,216
Cash, cash equivalents, and restricted cash at end of period 105,576 44,354
Interest paid 21,088 19,396
Non-cash changes in deferred funding obligations 175,970 13,041
Non-cash changes in financing receivables and investments (175,970) (26,456)
Non-cash changes in residual assets $ (11,061) $ (7,095)